---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-044917"
form_type: "8-K"
ticker: "CELU"
cik: "0001752828"
company_name: "Celularity Inc"
filed_at: "2026-09-29T21:25:51+00:00"
generated_at: "2026-10-12T13:54:25.855725+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Celularity adds Viome CEO Naveen Jain to board; Diane Parks resigns; fifth director expected

## Summary
- Naveen Jain, founder and CEO of Viome Life Sciences, appointed to Celularity's board, effective once the Rule 14f-1 information statement process completes.
- Director Diane Parks resigned effective at that same time; Celularity said her decision was not the result of any disagreement over operations, policies or practices.
- Jain's seat comes from board designation rights granted to investors in the September 2026 financing, previously disclosed in the Form 8-K filed September 28, 2026.
- Board now consists of CEO Robert J. Hariri, Peter H. Diamandis, Philip A. Barach and Jain; Celularity said it expects to announce a fifth director shortly.
- Jain receives standard non-employee director compensation, is expected to sign the company's standard indemnification agreement, and has no initial committee assignments.

## SEC filing metadata
- accession: 0001493152-26-044917
- form_type: 8-K
- ticker: CELU
- cik: 0001752828
- company_name: Celularity Inc
- filed_at: 2026-09-29T21:25:51+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1752828/000149315226044917/0001493152-26-044917-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1752828/000149315226044917/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-044917
- JSON: https://secwatch.observer/filing/0001493152-26-044917.json
- Plain text: https://secwatch.observer/filing/0001493152-26-044917.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.